InsidersTradesSigma
尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
Discover the detailed record of transactions filed by Campbell David Alan. Director active across 1 company, notably Janux Therapeutics, Inc.. Cumulatively, 10 filings have been recorded. Breakdown: 0 buy · 7 sells. Total volume traded: €5.1m. Activity tracked since 27 September 2024. The latest transaction was disclosed on 31 July 2026 (Don). Regulator: SEC (Form 4). The full history is accessible without signup.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
10 条申报中的 10 条
Campbell David Alan is associated with Janux Therapeutics, Inc., where he holds the role of President and CEO. He has 7 filings in total, and across the 7 sampled recent filings between 2024-09-27 and 2025-01-08, they are sales for a total amount of EUR 4959845, with the transaction nature indicated as Sale.